Fennec Pharmaceuticals (FENC) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts FENC Hot Sheet
Join SI Premium – FREE
Fennec Pharmaceuticals (NASDAQ: FENC) reported Q4 EPS of ($0.06), $0.07 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $7.92 million versus the consensus estimate of $7.88 million.
For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q4 EPS by 4c
- Qualcomm to launch data center CPU in mid-2028 - Data Center Chief
- HeartBeam shifts to licensing model, replaces CEO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
